6568 — KNC Laboratories Co Cashflow Statement
0.000.00%
Last trade - 00:00- ¥8bn
- ¥8bn
- ¥9bn
- 64
- 87
- 55
- 81
Annual cashflow statement for KNC Laboratories Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 705 | 586 | 917 | 2,172 | 2,093 |
| Depreciation | |||||
| Non-Cash Items | 117 | 85.2 | 30.8 | 123 | -26.3 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1,583 | -284 | -1,292 | -1,221 | 215 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 42.2 | 1,327 | 585 | 1,994 | 3,205 |
| Capital Expenditures | -1,940 | -892 | -833 | -1,130 | -2,352 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 76.5 | 232 | 220 | -16.7 | -16.8 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -1,863 | -660 | -614 | -1,147 | -2,369 |
| Financing Cash Flow Items | -2.44 | -1.61 | -0.424 | -0.227 | -0.062 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 255 | -180 | 39 | -523 | 179 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -1,566 | 487 | 10.6 | 324 | 1,014 |